Affibody-based nanoprobes for HER2-expressing cell and tumor imaging

Biomaterials

Volumn 32, Issue 8, 2011, Pages 2141-2148

  Gao, Jinhao ^a,b   Chen, Kai ^a   Miao, Zheng ^a   Ren, Gang ^a   Chen, Xiaoyuan ^c   Gambhir, Sanjiv S ^a,d   Cheng, Zhen ^a  

^a STANFORD UNIVERSITY   (United States)

^b XIAMEN UNIVERSITY   (China)

^c NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^d Stanford University   (United States)

Author keywords

Affibody; Bioconjugation; HER2; Molecular imaging; Nanoprobes

Indexed keywords

AFFIBODY; AFFIBODY MOLECULES; BIO-CONJUGATION; CYSTEINE RESIDUES; FUNCTIONALIZED NANOPARTICLES; HER2; HIGH AFFINITY; HUMAN EPIDERMAL GROWTH FACTOR; IN-VITRO; MALEIMIDES; MOLECULAR IMAGING; NANO-MATERIALS; NEAR INFRA RED; QUANTUM DOTS; TUMOR IMAGING;

AMINO ACIDS; INFRARED DEVICES; IRON OXIDES; NANOPARTICLES; SEMICONDUCTOR QUANTUM DOTS; TUMORS;

NANOPROBES;

CYSTEINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; IRON OXIDE; MALEIMIDE; NANOMATERIAL; NANOPARTICLE; QUANTUM DOT;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR IMAGING; MOUSE; NANOPROBE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE;

ANIMALS; CELL LINE, TUMOR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METAL NANOPARTICLES; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; MODELS, MOLECULAR; MOLECULAR IMAGING; NEOPLASMS; POLYETHYLENE GLYCOLS; QUANTUM DOTS; RECEPTOR, ERBB-2; RECOMBINANT FUSION PROTEINS; TISSUE DISTRIBUTION;

EID: 78651464824     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.11.053     Document Type: Article

References (45)

1. Miao Z., Levi J., Cheng Z. Protein scaffold-based molecular probes for cancer molecular imaging. Amino Acids 2010, 10.1007/s00726-010-0503-9.
2. Nilsson F.Y., Tolmachev V. Affibody molecules: new protein domains for molecular imaging and targeted tumor therapy. Curr opinion drug discovery Development 2007, 10:167-175.
3. Binz H.K., Amstutz P., Pluckthun A. Engineering novel binding proteins from nonimmunoglobulin domains. Nat Biotechnol 2005, 23:1257-1268.
4. Alexis F., Basto P., Levy-Nissenbaum E., Radovic-Moreno A.F., Zhang L., Pridgen E., et al. HER-2-targeted nanoparticle-Affibody bioconjugates for cancer therapy. ChemMedChem 2008, 3:1839-1843.
5. Cheng Z., De Jesus O.P., Namavari M., De A., Levi J., Webster J.M., et al. Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules. J Nucl Med 2008, 49:804-813.
6. Tolmachev V., Nilsson F.Y., Widstrom C., Andersson K., Rosik D., Gedda L., et al. 111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors. J Nucl Med 2006, 47:846-853.
7. Orlova A., Nilsson F.Y., Wikman M., Widstrom C., Stahl S., Carlsson J., et al. Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors. J Nucl Med 2006, 47:512-519.
8. Orlova A., Magnusson M., Eriksson T.L., Nilsson M., Larsson B., Hoiden-Guthenberg I., et al. Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res 2006, 66:4339-4348.
9. Tolmachev V., Orlova A., Pehrson R., Galli J., Baastrup B., Andersson K., et al. Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule. Cancer Res 2007, 67:2773-2782.
10. Kramer-Marek G., Kiesewetter D.O., Martiniova L., Jagoda E., Lee S.B., Capala J. [F-18]FBEM-Z(HER2: 342) - Affibody molecule - a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography. Eur J Nucl Med Mol Imaging 2008, 35:1008-1018.
11. Cheng Z., De Jesus O.P., Kramer D.J., De A., Webster J.M., Gheysens O., et al. (64)Cu-labeled Affibody molecules for imaging of HER2 expressing tumors. Mol Imaging Biol 2010, 12:316-324.
12. Ren G., Zhang R., Liu Z., Webster J.M., Miao Z., Gambhir S.S., et al. A 2-helix small protein labeled with 68Ga for PET imaging of HER2 expression. J Nucl Med 2009, 50:1492-1499.
13. Gong H.B., Kovar J., Little G., Chen H.X., Olive D.M. In vivo imaging of xenograft tumors using an Epidermal Growth Factor Receptor-specific affibody molecule labeled with a near-infrared fluorophore. Neoplasia 2010, 12:139-149.
14. Miao Z., Ren G., Liu H.G., Jiang L., Cheng Z. Cy5.5 labeled affibody molecule for near-infrared optical imaging of Epidermal Growth Factor Receptor1 expression. J Biomed Opt 2010, 15:036007.
15. Michalet X., Pinaud F.F., Bentolila L.A., Tsay J.M., Doose S., Li J.J., et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307:538-544.
16. Gill R., Zayats M., Willner I. Semiconductor quantum dots for bioanalysis. Angew Chem. Int Edit 2008, 47:7602-7625.
17. Smith A.M., Duan H.W., Mohs A.M., Nie S.M. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev 2008, 60:1226-1240.
18. Yong K.T., Roy I., Swihart M.T., Prasad P.N. Multifunctional nanoparticles as biocompatible targeted probes for human cancer diagnosis and therapy. J Mater Chem 2009, 19:4655-4672.
19. Corot C., Robert P., Idee J.M., Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 2006, 58:1471-1504.
20. McCarthy J.R., Weissleder R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 2008, 60:1241-1251.
21. Gao J.H., Gu H.W., Xu B. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc Chem Res 2009, 42:1097-1107.
22. Cai W.B., Chen X.Y. Nanoplatforms for targeted molecular imaging in living subjects. Small 2007, 3:1840-1854.
23. Douma K., Prinzen L., Slaaf D.W., Reutelingsperger C.P.M., Biessen E.A.L., Hackeng T.M., et al. Nanoparticles for optical molecular imaging of atherosclerosis. Small 2009, 5:544-557.
24. Gao J.H., Xu B. Applications of nanomaterials inside cells. Nano Today 2009, 4:37-51.
25. Mulder W.J.M., Strijkers G.J., Van Tilborg G.A.F., Cormode D.P., Fayad Z.A., Nicolay K. Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging. Acc Chem Res 2009, 42:904-914.
26. Rabin O., Perez J.M., Grimm J., Wojtkiewicz G., Weissleder R. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater 2006, 5:118-122.
27. De la Zerda A., Zavaleta C., Keren S., Vaithilingam S., Bodapati S., Liu Z., et al. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat Nanotechnol 2008, 3:557-562.
28. Choi H.S., Liu W., Liu F., Nasr K., Misra P., Bawendi M.G., et al. Design considerations for tumour-targeted nanoparticles. Nat Nanotechnol 2010, 5:42-47.
29. Gao X.H., Cui Y.Y., Levenson R.M., Chung L.W.K., Nie S.M. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22:969-976.
30. Weissleder R., Kelly K., Sun E.Y., Shtatland T., Josephson L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 2005, 23:1418-1423.
31. Xie R.G., Chen K., Chen X.Y., Peng X.G. InAs/InP/ZnSe core/shell/shell quantum dots as near-infrared emitters: bright, narrow-band, non-cadmium containing, and biocompatible. Nano Res 2008, 1:457-464.
32. Xie J., Chen K., Huang J., Lee S., Wang J.H., Gao J.H., et al. PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials 2010, 31:3016-3022.
33. Dubertret B., Skourides P., Norris D.J., Noireaux V., Brivanlou A.H., Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002, 298:1759-1762.
34. Carion O., Mahler B., Pons T., Dubertret B. Synthesis, encapsulation, purification and coupling of single quantum dots in phospholipid micelles for their use in cellular and in vivo imaging. Nat Protoc 2007, 2:2383-2390.
35. Cai W.B., Shin D.W., Chen K., Gheysens O., Cao Q.Z., Wang S.X., et al. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett 2006, 6:669-676.
36. Ito A., Ino K., Kobayashi T., Honda H. The effect of RGD peptide-conjugated magnetite cationic liposomes on cell growth and cell sheet harvesting. Biomaterials 2005, 26:6185-6193.
37. Verma A., Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small 2010, 6:12-21.
38. Yang L.L., Mao H., Wang Y.A., Cao Z.H., Peng X.H., Wang X.X., et al. Single chain Epidermal Growth Factor Receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. Small 2009, 5:235-243.
39. Gao J.H., Chen K., Xie R.G., Xie J., Lee S., Cheng Z., et al. Ultrasmall near-infrared non-cadmium quantum dots for in vivo tumor imaging. Small 2010, 6:256-261.
40. Gao J.H., Chen K., Xie R.G., Xie J., Yan Y.J., Cheng Z., et al. In vivo Tumor-targeted fluorescence imaging using near-infrared non-cadmium quantum dots. Bioconjug Chem 2010, 21:604-609.
41. Ullen A., Lennartsson L., Harmenberg U., Lennernas B., Majumder K., Holmberg A.R., et al. Prostate cancer cell lines lack amplification: overexpression of HER2. Acta Oncol 2005, 44:490-495.
42. Choi H.S., Liu W.H., Misra P., Tanaka E., Zimmer J.P., Ipe B.I., et al. Renal clearance of quantum dots. Nat Biotechnol 2007, 25:1165-1170.
43. Law W.C., Yong K.T., Roy I., Ding H., Hu R., Zhao W.W., et al. Aqueous-phase synthesis of highly luminescent CdTe/ZnTe core/shell quantum dots optimized for targeted bioimaging. Small 2009, 5:1302-1310.
44. Yong K.T., Roy I., Ding H., Bergey E.J., Prasad P.N. Biocompatible near-infrared quantum dots as ultrasensitive probes for long-term in vivo imaging applications. Small 2009, 5:1997-2004.
45. Ferrucci J.T., Stark D.D. Iron-oxide enhanced MR-imaging of the liver and spleen - Review of the 1st-5 years. Am J Roentgenol 1990, 155:943-950.